Botanix (ASX:BOT) investor centre
Botanix is a publicly listed, leading pharmaceutical company leveraging the unique properties of synthetic cannabinoids.
Botanix Investor Centre
Botanix is an ASX-listed company (ASX:BOT), in a prime position for growth and to return value for shareholders. With deep expertise in dermatology and pharmaceutical product commercialisation, we are on track to disrupt some of the most lucrative global healthcare markets.
ASX: BOT | Share price
ASX Releases
| Title | Size | Date |
|---|---|---|
| PDF • 13.8 MB | 30 Jun 2025 07:49pm | |
| PDF • 17.5 MB | 30 Jun 2025 07:49pm | |
| PDF • 1,073.8 MB | 27 Jun 2025 04:55pm | |
| PDF • 19.3 MB | 11 Jun 2025 06:07pm | |
| PDF • 20.3 MB | 10 Jun 2025 08:54am | |
| PDF • 308.5 MB | 10 Jun 2025 08:39am | |
| PDF • 242.0 MB | 23 May 2025 09:06am | |
| PDF • 155.8 MB | 23 May 2025 08:18am | |
| PDF • 13.8 MB | 21 May 2025 05:23pm | |
| PDF • 17.9 MB | 21 May 2025 05:22pm | |
| PDF • 189.8 MB | 14 May 2025 04:39pm | |
| PDF • 790.2 MB | 12 May 2025 12:26pm | |
| PDF • 175.2 MB | 12 May 2025 12:26pm | |
| PDF • 115.0 MB | 12 May 2025 10:48am | |
| PDF • 203.8 MB | 06 May 2025 05:38pm | |
| PDF • 227.5 MB | 01 May 2025 04:37pm | |
| PDF • 130.9 MB | 24 Apr 2025 05:29pm | |
| PDF • 17.3 MB | 24 Apr 2025 05:27pm | |
| PDF • 1,156.3 MB | 24 Apr 2025 02:05pm | |
| PDF • 177.7 MB | 15 Apr 2025 09:55am |
Corporate Governance & Policies
- 2024 Corporate Governance Statement
- Mission and Values Statement
- Shareholder Communication Policy
- Continuous Disclosure Policy
- Performance Evaluation Policy
- Risk Management Framework
- Risk Management and Internal Control Policy
- Whistleblower Policy
- Anti-Bribery and Anti-Corruption Policy
- Diversity Policy
- Board Charter
- Code of Conduct
- Securities Trading Policy
- Employee Awards Plan
- Audit and Risk Management Committee Charter
- Remuneration and Nomination Committee Charter
- US State Compliance
Share Registry & Shareholder Communications
Click here to access a full overview of Botanix’s Shareholder Communications
Share Registry
Our share and options registers are maintained by Automic Group (Automic)
Security holders who wish to update personal or contact information, elect to receive communications electronically (such as the company’s annual report or notice of meeting), or provide banking details can do so via the Automic website and follow the prompts, or contact Automic using the details below.
When updating information electronically or contacting Automic, you will need your Security Reference Number (SRN) or Holder Identification Number (HIN), along with your postcode. These details are available on your Issuer Sponsored or CHESS statements.
Share Registry Contact Details
- Website: investor.automic.com.au
- Phone: 1300 288 664 (Australia) | +61 (0)2 9698 5414 (Overseas)
- Email: hello@automicgroup.com.au
Investor Presentations
- 8 May 2024 – Commercial Day Webinar
- 11 March 2024 – Euroz Hartleys Institutional Conference
- 6 February 2024 – Euroz Hartleys Healthcare Forum Presentation
- 8 November 2023 – Annual General Meeting Presentation
- 31 October 2023 – Investor Update
- 26 September 2023 – Update regarding NDA filing for Sofpironium Bromide
- 24 July 2023 – Bioshares Conference 2023
- 7 June 2023 – Investor Webinar
- 5 April 2023 – Positive FDA mid-cycle review results – Sofpironium Bromide
- 9 March 2023 – Updated Commercial Research for Sofpironium Bromide
- 31 January 2023 – Preparing for FDA mid-cycle review (Q1 2023)
- 9 January 2023 – JP Morgan Healthcare Conference
- 23 November 2022 – Annual General Meeting Presentation
- 18 November 2022 – Initial market research – Sofpironium Bromide
- 13 October 2022 – BTX 1702 Phase 1b/2 Clinical Study – Rosacea
- 22 March 2017 – Botanix Corporate Presentation